CLINICAL_TRIALS
trial_result
· 2011-11-16
Clinical Trial Update: Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis [Phase 3]
Summary
Phase 3 study evaluating zoledronic acid in men with osteoporosis reports efficacy in reducing fractures and summarizes safety findings.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Male Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2011-11-16